| Literature DB >> 34993769 |
Arun Jerang1, Sony Kumari2, Madhushmita Borthakur2, Shahbaaz Ahmed2.
Abstract
In the historical mysteries and present pandemic situation, the use of citrus fruits makes it rise high among other fruits. Citrus has a significant role in dietary and medicinal purposes from time immemorial and widely acknowledged for its therapeutic properties. Citrus megaloxycarpa Lush. is an unspecified sibling of the citrus family. The present work highlights the biochemical, antimicrobial, and anticancerous potential of cryptic species indigenous to Northeast India. The research was done on peel; P(L1) and pulp; Pu(L2) extracts of ripe large and peel; P(L1) and pulp; Pu(L2) extracts unripe small varieties respectively. The extract of the Pu(L2) has the highest total soluble sugar (9.174±0.006741 μg/ml) whereas the extract of P(S1) demonstrated high protein concentration (8.074±0.0567 μg/ml). The total carbohydrate content also varied in the extracts; the extract of P(L1) showed (8.326±0.003844 μg/ml). P(L1) have high free amino acid content (24.35±0.0225μg/ml) and high free fatty acid exhibited on P(L2) (0.3739±0.05774 μg/ml). The total DPPH scavenging activity was compared for the extracts, where the extract of Pu (S1) exhibits highest activity 73.80% and 0.6577 of logIC50 value. The highest total antioxidant capacity displays 150±0.333 in P(L1). The MIC value was calibrated (30%, 35%, 40%, 45%) (v/v) and found to be maximum in P(L2) (0.695) and minimum in P(L1) (0.163) against Salmonella typhi and Escherichia coli. MTT assay showed highest viability rate of 94.32% and toxicity rate of 8.56% achieved on mouse lung cancerous cell. It is quite obvious from the present research that Citrus megaloxycarpa Lush. has a great scope at industrial level for developing therapeutic drugs.Entities:
Keywords: Anticancerous; Antimicrobial; Antioxidant; Cryptic; Therapeutic
Mesh:
Substances:
Year: 2022 PMID: 34993769 PMCID: PMC8734548 DOI: 10.1007/s12010-021-03786-4
Source DB: PubMed Journal: Appl Biochem Biotechnol ISSN: 0273-2289 Impact factor: 2.926
Fig. 1Morphology and cross-section of Citrus megaloxycarpa Lush.
Biochemical assay of Citrus megaloxycarpa Lush.
| Peel extract (L1) | Pulp extract (L2) | Peel extract | Pulp extract (S2) | |
|---|---|---|---|---|
| Total soluble sugar content (μg/ml) ±SEM | 7.823 ± 0.03553 | 9.174 ± 0.006741 | 6.254 ± 0.006928 | 7.496 ± 0.03017 |
| Total soluble protein content (μg/ml) ±SEM | 6.673± 0.0176 | 6.537 ± 0.0318 | 8.074 ± 0.0567 | 6.643 ± 0.09074 |
Total carbohydrate content (μg/ml) ±SEM | 8.326 ± 0.003844 | 2.352 ± 0.1159 | 4.026 ± 0.0005696 | 2.240 ± 0.0008819 |
| Free amino acids content (μg/ml) ±SEM | 24.35 ± 0.0225 | 24.22 ± 0.01289 | 24.12 ± 0.00115 | 24.03 ± 0.00881 |
| Free fatty acid content (μg/ml) ±SEM | 0.2614±0.03333 | 0.3739±0.05774 | 0.3552±0.03333 | 0.2614±0.03333 |
Result is expressed in mean ± SEM, n = 3, **** (P< 0.0001) ‘t’ test
IC50 DPPH scavenging activity of Citrus megaloxycarpa Lush.
logIC50 = 0.6527 IC50 = 89.9 | logIC50 = 0.6577 IC50 = 90.94 | logIC50 = 0.5088 IC50 = 64.54 | logIC50 = 0.5122 IC50 = 65.04 |
Result shown in % mean, n = 3, **** (level of significance) P<0.0001 by ‘t’ test
Fig. 2DPPH free radical (%) scavenging activity of Citrus megaloxycarpa Lush. extracts
Fig. 3Total antioxidant capacity (%) of Citrus megaloxycarpa Lush. extracts
Fig. 4Minimum inhibitory concentration of citrus extracts vs standard antibiotic used
Inhibitory concentration of different standards used
| 0.162 | ||
| 0.336 | ||
| 0.221 | ||
| 0.205 | ||
| 0.267 | ||
| 0.275 | ||
| 0.328 | ||
| 0.154 |
Cell cytotoxicity (MTT assay) result
| Pulp extract (L1) | 94.32 | 5.67 |
| Peel extract (L2) | 94.32 | 5.67 |
| Pulp extract (S1) | 91.44 | 8.56 |
| Peel extract (S2) | 92.32 | 7.68 |